Literature DB >> 25618420

Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.

Teske Schoffelen1, Joshua S Self2, Kelly A Fitzpatrick2, Mihai G Netea1, Marcel van Deuren1, Leo A B Joosten1, Gilbert J Kersh3.   

Abstract

Coxiella burnetii, a Gram-negative intracellular bacterium, can give rise to Q fever in humans and is transmitted mainly by inhalation of infected aerosols from animal reservoirs. Serology is commonly used to diagnose Q fever, but the early cellular immune response-i.e., C. burnetii-specific interferon γ (IFN-γ) production in response to antigen challenge-might be an additional diagnostic. Detection of IFN-γ responses has been used to identify past and chronic Q fever infections, but the IFN-γ response in acute Q fever has not been described. By challenging immunocompetent BALB/c mice with aerosols containing phase I C. burnetii, the timing and extent of IFN-γ recall responses were evaluated in an acute C. burnetii infection. Other cytokines were also measured in an effort to identify other potential diagnostic markers. The data show that after initial expansion of bacteria first in lungs and then in other tissues, the infection was cleared from day 10 onwards as reflected by the decreasing number of bacteria. The antigen-induced IFN-γ production by splenocytes coincided with emergence of IgM phase II antibodies at day 10 postinfection and preceded appearance of IgG antibodies. This was accompanied by the production of proinflammatory cytokines including interleukin (IL) 6, keratinocyte-derived cytokine, and IFN-γ-induced protein 10, followed by monocyte chemotactic protein 1, but not by IL-1β and tumor necrosis factor α, and only very low production of the anti-inflammatory cytokine IL-10. These data suggest that analysis of antigen-specific IFN-γ responses could be a useful tool for diagnosis of acute Q fever. Moreover, the current model of C. burnetii infection could be used to give new insights into immunological factors that predispose to development of persistent infection. Published by Elsevier Inc.

Entities:  

Keywords:  Cellular immunity; Coxiella burnetii; Cytokines; Interferon-gamma; Q fever; Serology

Mesh:

Substances:

Year:  2014        PMID: 25618420      PMCID: PMC4740919          DOI: 10.1016/j.diagmicrobio.2014.12.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  35 in total

1.  Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing.

Authors:  Eric Ghigo; Christian Capo; Ching-Hsuan Tung; Didier Raoult; Jean-Pierre Gorvel; Jean-Louis Mege
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.

Authors:  Teske Schoffelen; Tineke Herremans; Tom Sprong; Marrigje Nabuurs-Franssen; Peter C Wever; Leo A B Joosten; Mihai G Netea; Jos W M van der Meer; Henk A Bijlmer; Marcel van Deuren
Journal:  J Infect       Date:  2013-08-22       Impact factor: 6.072

3.  A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever.

Authors:  T Schoffelen; T Sprong; C P Bleeker-Rovers; M C A Wegdam-Blans; A Ammerdorffer; M J H Pronk; Y E P Soethoudt; M E E van Kasteren; T Herremans; H A Bijlmer; M G Netea; J W M van der Meer; L A B Joosten; M van Deuren
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

4.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.

Authors:  Robert E Brennan; Kasi Russell; Guoquan Zhang; James E Samuel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever.

Authors:  Amélie Honstettre; Guenièvre Imbert; Eric Ghigo; Frédérique Gouriet; Christian Capo; Didier Raoult; Jean-Louis Mege
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

7.  Q fever in humans and animals in the United States.

Authors:  Jennifer H McQuiston; James E Childs
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

8.  Structure and biological relationships of Coxiella burnetii lipopolysaccharides.

Authors:  K Amano; J C Williams; S R Missler; V N Reinhold
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

9.  Animal models in Q fever: pathological responses of inbred mice to phase I Coxiella burnetii.

Authors:  G H Scott; J C Williams; E H Stephenson
Journal:  J Gen Microbiol       Date:  1987-03

10.  Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects.

Authors:  A A Izzo; B P Marmion
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

View more
  10 in total

1.  Mouse Model of Coxiella burnetii Aerosolization.

Authors:  Cléa Melenotte; Hubert Lepidi; Claude Nappez; Yassina Bechah; Gilles Audoly; Jérôme Terras; Didier Raoult; Fabienne Brégeon
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

2.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.

Authors:  Talita D Fernandes; Larissa D Cunha; Juliana M Ribeiro; Liliana M Massis; Djalma S Lima-Junior; Hayley J Newton; Dario S Zamboni
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  CXCL9, a promising biomarker in the diagnosis of chronic Q fever.

Authors:  Anne F M Jansen; Teske Schoffelen; Julien Textoris; Jean-Louis Mege; Marrigje Nabuurs-Franssen; Ruud P H Raijmakers; Mihai G Netea; Leo A B Joosten; Chantal P Bleeker-Rovers; Marcel van Deuren
Journal:  BMC Infect Dis       Date:  2017-08-09       Impact factor: 3.090

5.  Early Cytokine Response After Vaccination with Coxiella Burnetii Phase I in an Infected Herd of Dairy Cattle.

Authors:  Joanna Małaczewska; Edyta Kaczorek-Łukowska; Monika Szymańska-Czerwińska; Wojciech Rękawek; Roman Wójcik; Krzysztof Niemczuk; Andrzej Krzysztof Siwicki
Journal:  J Vet Res       Date:  2018-12-31       Impact factor: 1.744

6.  Comparison of three Coxiella burnetii infectious routes in mice.

Authors:  Halie K Miller; Rachael A Priestley; Gilbert J Kersh
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Coxiella burnetii infections in mice: Immunological responses to contemporary genotypes found in the US.

Authors:  Rachael A Priestley; Cody B Smith; Halie K Miller; Gilbert J Kersh
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 8.  Preclinical Animal Models for Q Fever Vaccine Development.

Authors:  Mahelat Tesfamariam; Picabo Binette; Carrie Mae Long
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

Review 9.  Q Fever-A Neglected Zoonosis.

Authors:  Qudrat Ullah; Tariq Jamil; Muhammad Saqib; Mudassar Iqbal; Heinrich Neubauer
Journal:  Microorganisms       Date:  2022-07-28

10.  Transmission of Coxiella burnetii by ingestion in mice.

Authors:  H K Miller; R A Priestley; G J Kersh
Journal:  Epidemiol Infect       Date:  2020-02-05       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.